|
Does ADHD look the same in youth of different races?
March 20, 2008Research published by SAGE in Journal of Attention Disorders
The research in the article looked at childhood ADHD in underrepresented minorities, reviewing controversy around evaluation, diagnosis, and obstacles faced by families, ending with recommendations for assessment and treatment. Studying causes and consequences of untreated ADHD in minority children, the article considers:
* evaluating the child's physical and neurological responses
* assessing family history, including health issues
* building rapport between the family, the school and the health care provider
* recommendations, including psychotherapy, medication and behavioral interventions
* removing barriers such as lack of finances, health care providers and insurance
* maintaining cultural awareness and providing community educational campaigns
"A child of any race can be deeply affected by attention difficulties not only during school years but for a lifetime," writes coauthor Heather Hervey-Jumper. "It is tragic that many minority children are not provided with culturally sensitive assessments when we have effective treatments that can start these children on a track of progress. Untreated attention disorders can cause devastating results and we believe there are solutions for children of all ethnic backgrounds."
SAGE Publications
* assessing family history, including health issues
* building rapport between the family, the school and the health care provider
* recommendations, including psychotherapy, medication and behavioral interventions
* removing barriers such as lack of finances, health care providers and insurance
* maintaining cultural awareness and providing community educational campaigns
"A child of any race can be deeply affected by attention difficulties not only during school years but for a lifetime," writes coauthor Heather Hervey-Jumper. "It is tragic that many minority children are not provided with culturally sensitive assessments when we have effective treatments that can start these children on a track of progress. Untreated attention disorders can cause devastating results and we believe there are solutions for children of all ethnic backgrounds."
SAGE Publications
ADHD News and Current ADHD Events RSSDid the gene for ADHD help our nomadic ancestors?
An ADHD-associated version of the human gene DRD4 is linked to better health among nomadic tribesmen, but may cause malnourishment in their settled cousins, according to new research by a team directed by an anthropologist at the University of Wisconsin-Milwaukee (UWM).
PET imaging focuses on medication's purported ability to improve mental performance
Concerned by the growing numbers of people using stimulant medications such as methylphenidate (MP)-either legally or illegally-to improve attention and focus, researchers used positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) to assess the effects of the drug on brain function in the normal human brain.
Knowing looks: Using gaze aversion to tell when children are learning
People use eye contact in a variety of ways every minute of every day but how often do you find yourself staring into space with concentrating on an issue or problem? Psychologists now know that people who are carrying out a complex task tend to look away from anyone else who is nearby. They refer to it as 'gaze aversion'.
Report confirms increased risk of smoking, substance abuse in bipolar adolescents
A study from the Massachusetts General Hospital (MGH) supports previous reports that adolescents with bipolar disorder are at increased risk for smoking and substance abuse.
Children's diet not the main cause of ADHD
Food may not be the major cause of hyperactivity in children. Genetics, brain function and parental actions such as smoking may be just as important.
A trial of removing food additives should be considered for hyperactive children
A properly supervised trial eliminating colours and preservatives from the diet of hyperactive children should considered a part of the standard treatment, says an editorial in this week's BMJ.
Phase III pivotal results presented of VYVANSE to treat ADHD in adults
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults and met all safety and efficacy endpoints.
New analysis shows DAYTRANA offered ADHD symptom control for 12 months
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced findings from a new data analysis that was conducted to examine treatment differences with DAYTRAN (methylphenidate transdermal system) between boys and girls aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD).
Children more vulnerable to harmful effects of lead
Contrary to prevailing assumptions, children are more vulnerable to the harmful effects of lead exposure at the age of 6 than they are in early childhood, according to a Cincinnati Children's Hospital Medical Center study to be presented May 4 at the annual meeting of the Pediatric Academic Societies in Honolulu.
Children with ADHD should get heart tests before treatment with stimulant drugs
Children with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before treatment with stimulant drugs, a new American Heart Association statement recommends.
More ADHD News Articles
| © 2008 BrightSurf.com |